Plain-English translation of NCT07468071 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This is a continuation study for people who have been taking in a previous cancer trial and are still doing well on it. You would keep taking the same medication at the same dose you were already receiving—either alone or combined with other study drugs—rather than stopping treatment.
When someone's cancer is responding well to a medication, stopping it abruptly can cause problems. This study exists to let people continue receiving the treatment that is helping them, rather than having to wait for or switch to something else.
You likely qualify if…
You likely don't qualify if…
You would continue coming to clinic visits on a regular schedule to pick up your medication, have safety check-ins, and let your doctor confirm the treatment is still helping. You would take the same medication at the same dose you were already on, either by itself or combined with other drugs, and treatment continues until your cancer progresses or you experience side effects that require stopping. The study lasts up to three years total, with follow-up visits for 1–5 months after you stop taking the medication.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
Belgium
Canada
China